about
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (...
Read More
11.42
0.23
(2.06%)
9.3M
XNAS Volume
High volume today
XNAS 12 Nov, 2025 4:30 PM (EST)
Board Meeting
The next board meeting for CorMedix Inc is on 21 Nov 2025 for the purpose of Cormedix Inc Annual General Meeting for 2025
See details
Medium Financial Strength
Mid Valuation
Technically Neutral
Mid-range Performer
These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks.
View Similar
Embed DVM
CorMedix Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..